Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
/in International Publications, Malignant Melanoma /von 2005-03-18 / Vaccine 2005 Mar;23(17-18):2367-73Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2005-03-11 / Am. J. Respir. Crit. Care Med. 2005 May;171(10):1168-77Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2005-03-01 / Cancer Gene Ther. 2005 Mar;12(3):295-303The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)
/in Dendritic Cells, International Publications, NSCLC /von 2005-03-01 / Lung Cancer 2005 Mar;47(3):337-50Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons
/in HIV/AIDS, International Publications /von 2005-03-01 / J. Virol. 2005 Mar;79(5):3052-62A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma
/in International Publications, NSCLC /von 2005-02-15 / Cancer 2005 Feb;103(4):763-71Effects of dendritic cells transfected with full length wild-type p53 and modified by bile duct cancer lysates on immune response
/in Gallbladder Cancer, International Publications /von 2005-02-01 / HBPD INT 2005 Feb;4(1):121-5A thermometry system for quality assurance and documentation of whole body hyperthermia procedures
/in Hyperthermia, International Publications /von 2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-55Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
/in Breast Cancer, Dendritic Cells, International Publications /von 2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de